Ligation of CR1 (C3b receptor, CD35) on CD4+ T lymphocytes enhances viral replication in HIV-infected cells

Clinical and Experimental Immunology

Volumn 106, Issue 2, 1996, Pages 297-303

  Mouhoub, A ^a   Delibrias, C C ^a   Fischer, E ^a   Boyer, V ^a   Kazatchkine, M D ^a,b  

^a INSERM   (France)

^b HÔPITAL BROUSSAIS   (France)

Author keywords

CD4+ T lymphocytes; CR1(CD35)complement receptor; HIV 1

Indexed keywords

CD4 ANTIGEN; COMPLEMENT COMPONENT C3B; COMPLEMENT RECEPTOR; GAG PROTEIN;

ANTIGEN ANTIBODY COMPLEX; ARTICLE; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PRIORITY JOURNAL; T LYMPHOCYTE; VIRUS REPLICATION;

EID: 0029822712     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1996.d01-844.x     Document Type: Article

References (28)

1. Bukrinsky MI, Stanwiek TL, Denpsey MP, Stevenson M. Quiescent T lymphocytes as an inducible virus reservoir in HIV-1 infection. Science 1991; 254:423 7.
2. Bednarik DP, Folks TM. Mechanisms of HIV-1 latency. AIDS 1992; 6:3 16.
3. Gaynor R. Cellular transcription factors involved in the regulation of HIV-1 gene expression. AIDS 1992; 6:347 63.
4. Zagury D, Bernard J, Leonard R, Cheynier R, Feldman M, Sarin PS, Gallo RC. Long-term cultures of HTLV III infected T cells: a model of cytopathology of T cell depletion in AIDS. Science 1986; 231:850 3.
5. Siekevitz M, Josephs SF, Dukovitch M, Peffer N, Wong-staal F, Greene WC. Activation of the HIV-1 LTR by T cell mitogens and the trans-activator protein of HTLV-1. Science 1987; 238:1575 8.
6. Osborn L, Kunkel S, Nabel GJ. Tumor necrosis factor α and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kB. Proc Natl Acad Sci USA 1989; 86:2336 40.
7. Tong-starksen SE, Luciw PA, Peterlin BM, Signaling through T lymphocyte surface proteins, TCR CD3 and CD28, activates the HIV-1 long terminal repeat, J Immunol 1989; 142:702 7.
8. Bressler P, Pantaleo G, Demaria A, Fauci AS. Anti-CD2 receptor antibodies activate the HIV long terminal repeat in T lymphocytes. J Immunol 1991; 147:2290 4.
9. Gruters RA, Otto SA, Verhoeven AJ, Verweij CL, Lier RAW, Miedema F. Non-mitogenic T cell activation signals are sufficient for induction of human immunodeficieney virus transcription. Eur J Immunol 1991; 21:167 72.
10. Asjo B, Cefai D, Debre P, Dudoit Y, Autran B. A novel mode of human immunodeficiency virus type 1 (HIV-1) activation: ligation of CD28 alone induces HIV-1 replication in naturally infected lymphocytes. J Virol 1993; 67:4395 8.
11. + T cells from human immunodeficiency virus type 1-donors. Proc Natl Acad Sci USA 1993; 90: 11094 8.
12. Feinberg MB, Greene WC. Molecular insights into human immunodeficiency virus type 1 pathogenesis. Curr Opin Immunol 1992; 4: 466 74.
13. Thieblemont N. Haeffner-cavaillon N, Cholley B, Weiss L, Kazatchkine MD. Triggering of complement receptor CR1 (CD35) and CR3 (CD11b/CD18) induces nuclear translocation of NFVκB (p50. p65) in human monocytes and enhances replication in HIV-infected monocytic cells. J Immunol 1995; 155:4861 7.
14. Wilson JG, Tedder TF, Fearon DT. Characterization of human T lymphocytes that express the C3b receptor. J Immunol 1983; 131: 684 9.
15. Fischer E, Delibrias C, Kazatchkine MD. Expression of CR2 (the C3dg/EBV receptor. CD21) on normal human peripheral blood T lymphocytes. J Immunol 1991; 146:865 9.
16. Delibrias C, Fischer E, Bismuth G, Kazatchkine MD. Expression, molecular association, and functions of C3 complement receptors CR1 (CD35) and CR2 (CD21) on the human T cell line HPB-ALL. J Immunol 1992; 149:768-74.
17. Cook J, Fischer E, Boucheix C, Misrahi M, Jouvin MH, Weiss L, Jack R, Kazatchkine MD. Mouse monocloncal antibodies to the human C3b receptor. Mol Immunol 1985; 22:531-9.
18. Tedder T, Clement LT, Cooper MD. Expression of C3d receptors during human B cell differentiation: immunofluorescence analysis with the HB-5 monoclonal antibody. J Immunol 1984; 133:678 83.
19. Arnaout MA, Melamed J, Tack BF, Colten H. Characterization of the human complement (C3b) receptor with a fluid phase C3b dimer. J Immunol 1981; 127:1348-54.
20. Boyer V, Desgranges C, Trabaud MA, Fischer E, Kazatchkine MD. Complement mediates human immunodeficiency virus type 1 infection of a human T cell line in a CD4- and antibody-independent fashion. J Exp Med 1991; 173:1151-8.
21. Dewar RL, Highbarger HC, Sarmiento MD et al. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma, J Infect Dis 1994; 170:1172-9.
22. Matthes T, Werner-Favre C, Tang H, Zhang X, Kindler V, Zubler RH. Cytokine mRNA expression during an in vitro response of human B lymphocytes: kinetics of B cell tumor necrosis factor α, interleukin (IL) 6, IL-10 and transforming 31 mRNAs. J Exp Med 1993; 178:521-8.
23. Weiss L, Delfraissy JF, Vasquez A, Wallon C, Galanaud P, Kazatchkine MD. Monoclonal antibodies to the human C3b C4b receptor (CR1) enhance specific B cell differentiation. J Immunol 1987; 138:2988-93.
24. Betz M, Filsinger S. Modulation of T cell functions through CR1 and CR3. Complement Inflamm 1991; 8:128.
25. Changelian PS, Fearon DT. Tissue specific phosphorylation of complement receptors CR1 and CR2. J Exp Med 1986; 163:101 15.
26. Folks TM, Clouse KA, Justement J, Rabson A, Duh E, Kehrl JH. Fauci AS. Tumor necrosis factor α induces expression of human immunodeficiency virus in a chronically infected T-cell clone. Proc Natl Acad Sci USA 1989; 86:2365 8.
27. Montefiori DC, Graham BS, Zhou JY, Zhou JT, Ahearn JM. Binding of human immunodeficiency virus type 1 to the C3b C4b receptor CR1 (CD35) and red blood cells in the presence of envelope-specific antibodies and complement. J Infect Dis 1994; 170:429-32.
28. Delibrias C, Kazatchkine MD, Fischer E. Evidence for the role of CR1 (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand J Immunol 1993; 38: 183-9.